Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Goodwill (2016 - 2025)

Historic Goodwill for Ekso Bionics Holdings (EKSO) over the last 10 years, with Q3 2025 value amounting to $431000.0.

  • Ekso Bionics Holdings' Goodwill changed 0.0% to $431000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $431000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $431000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Goodwill stood at $431000.0, which was down 0.0% from $431000.0 recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Goodwill ranged from a high of $431000.0 in Q4 2022 and a low of $431000.0 during Q4 2022
  • Over the past 4 years, Ekso Bionics Holdings' median Goodwill value was $431000.0 (recorded in 2022), while the average stood at $431000.0.
  • Over the last 5 years, Ekso Bionics Holdings' Goodwill had its largest YoY gain of 0.0% in 2023, and its largest YoY loss of 0.0% in 2023.
  • Over the past 4 years, Ekso Bionics Holdings' Goodwill (Quarter) stood at $431000.0 in 2022, then changed by 0.0% to $431000.0 in 2023, then changed by 0.0% to $431000.0 in 2024, then changed by 0.0% to $431000.0 in 2025.
  • Its last three reported values are $431000.0 in Q3 2025, $431000.0 for Q2 2025, and $431000.0 during Q1 2025.